Five insights from the Global Burden of Disease Study 2019
Top Cited Papers
Open Access
- 1 October 2020
- journal article
- editorial
- Published by Elsevier BV in The Lancet
- Vol. 396 (10258), 1135-1159
- https://doi.org/10.1016/s0140-6736(20)31404-5
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Is the long-term decline in cardiovascular-disease mortality in high-income countries over? Evidence from national vital statisticsInternational Journal of Epidemiology, 2019
- Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017The Lancet, 2018
- Forecasting Future Trends in Obesity across Europe: The Value of Improving SurveillanceObesity Facts, 2018
- Investing in non-communicable disease prevention and management to advance the Sustainable Development GoalsThe Lancet, 2018
- Health Effects of Overweight and Obesity in 195 Countries over 25 YearsThe New England Journal of Medicine, 2017
- Peering into the pharmaceutical “pipeline”: Investigational drugs, clinical trials, and industry prioritiesSocial Science & Medicine (1982), 2014
- Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013The Lancet, 2014
- Tracking the Pharmaceutical Pipeline: Clinical Trials and Global Disease BurdenClinical and Translational Science, 2014
- Lives saved by Global Fund-supported HIV/AIDS, tuberculosis and malaria programs: estimation approach and results between 2003 and end-2007BMC Infectious Diseases, 2010
- Improving diet and physical activity: 12 lessons from controlling tobacco smokingBMJ, 2005